13726 Federal Register / Vol. 89, No. 37 / Friday, February 23, 2024 / Notices 

Name of Committee: Infectious Diseases 

and Immunology B Integrated Review Group; 

HIV Immunopathogenesis and Vaccine 

Development Study Section. 

Date: March 18–19, 2024. 

Time: 9:00 a.m. to 7:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD 20892 (Virtual Meeting). 

Contact Person: Philip Owens, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Dr., Bethesda, MD 

20892, (301) 594–7394, owensp2@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; Small 

Business: The Cancer Biotherapeutics 

Development (CBD). 

Date: March 18–19, 2024. 

Time: 9:00 a.m. to 7:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Melrose Hotel, 2430 Pennsylvania 

Ave. NW, Washington, DC 20037. 

Contact Person: Laurie Ann Shuman Moss, 

Ph.D., Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Bethesda, MD 

20892, (301) 867–5309, laurie.shumanmoss@

nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; 

Fellowships: Cancer Immunology and 

Immunotherapy I. 

Date: March 18–19, 2024. 

Time: 9:30 a.m. to 6:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD 20892 (Virtual Meeting). 

Contact Person: Ola Mae Zack Howard, 

Ph.D., Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 4192, 

MSC 7806, Bethesda, MD 20892, 301–451– 

4467, howardz@mail.nih.gov. 

Name of Committee: Infectious Diseases 

and Immunology A Integrated Review Group; 

HIV Molecular Virology, Cell Biology, and 

Drug Development Study Section. 

Date: March 18–19, 2024. 

Time: 10:00 a.m. to 8:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD 20892 (Virtual Meeting). 

Contact Person: Kenneth A. Roebuck, 

Ph.D., Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 5214, 

MSC 7852, Bethesda, MD 20892, (301) 435– 

1166, roebuckk@csr.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.306, Comparative Medicine; 

93.333, Clinical Research, 93.306, 93.333, 

93.337, 93.393–93.396, 93.837–93.844, 

93.846–93.878, 93.892, 93.893, National 

Institutes of Health, HHS) 

Dated: February 16, 2024. 

Victoria E. Townsend, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2024–03672 Filed 2–22–24; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Privacy Act of 1974; System of 

Records 

AGENCY: National Institutes of Health 

(NIH), Department of Health and Human 

Services. 

ACTION: Rescindment of a system of 

records notice. 

SUMMARY: In accordance with the 

requirements of the Privacy Act of 1974, 

as amended, the Department of Health 

and Human Services (HHS), through the 

National Institutes of Health (NIH), is 

rescinding a system of records titled 

‘‘Administration: Senior Staff, HHS/ 

NIH/NIAID,’’ system number 09–25– 

0087. The records are no longer needed 

for agency business, so are no longer 

retrieved by names or other personal 

identifiers. Because of this, the records 

no longer qualify as a Privacy Act 

system of records, and it is appropriate 

to rescind the system of records. 

DATES: In accordance with 5 U.S.C. 

552a(e)(4), this notice is applicable 

upon publication. 

ADDRESSES: The public may submit 

written comments on this notice, by 

mail or email, to Dustin Close, Office of 

Management Assessment, National 

Institutes of Health, 6705 Rockledge 

Drive, Suite 601, Bethesda, MD 20892, 

or email privacy@mail.nih.gov. 

FOR FURTHER INFORMATION CONTACT: 

General questions about the system of 

records may be submitted to Dustin 

Close, Office of Management 

Assessment, National Institutes of 

Health, 6705 Rockledge Drive, Suite 

601, Bethesda, MD 20892, telephone 

301–496–4606, email privacy@

mail.nih.gov. 

SUPPLEMENTARY INFORMATION: HHS/NIH 

is rescinding a system of records, titled 

‘‘Administration: Senior Staff, HHS/ 

NIH/NIAID,’’ system number 09–25– 

0087. The records consist of paper files 

containing biographical information 

about key professional employees and 

consultants that was used for public 

announcements and press releases about 

National Institute of Allergy and 

Infectious Diseases (NIAID) research. 

The records have not been used since 

2013 and are no longer needed for 

agency business, so are no longer 

retrieved by personal identifier. For 

these reasons, the records no longer 

qualify as a Privacy Act system of 

records. Because they have historical 

value, they will be transferred to the 

Office of NIH History and Stetten 

Museum for continued preservation, as 

authorized by National Archives and 

Records Administration-approved 

records disposition schedule 11–203 

(disposition authority DAA–GRS–2016– 

0005–0003), after removing any 

sensitive information. 

For the foregoing reasons, the below 

system of records is hereby rescinded: 

SYSTEM NAME AND NUMBER: 

Administration: Senior Staff, HHS/ 

NIH/NIAID, 09–25–0087. 

HISTORY: 

67 FR 60742 (Sept. 26, 2002), 83 FR 

6591 (Feb. 14, 2018). 

Alfred C. Johnson, 

Deputy Director for Management, National 

Institutes of Health. 

[FR Doc. 2024–03757 Filed 2–22–24; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HOMELAND 

SECURITY 

Coast Guard 

[Docket No. USCG–2024–0049] 

Issuance of Maritime Security 

(MARSEC) Directive 105–4; Cyber Risk 

Management Actions for Ship-to-Shore 

Cranes Manufactured by People’s 

Republic of China Companies 

AGENCY: Coast Guard, DHS. 

ACTION: Notice of availability. 

SUMMARY: The Coast Guard announces 

the availability of Maritime Security 

(MARSEC) Directive 105–4, which 

provides cyber risk management actions 

for owners or operators of ship-to-shore 

(STS) cranes manufactured by People’s 

Republic of China (PRC) companies 

(PRC-manufactured STS cranes). The 

directive contains security-sensitive 

information and, therefore, cannot be 

made available to the general public. 

Owners or operators of PRCmanufactured STS cranes should 

immediately contact their local Coast 

Guard Captain of the Port (COTP) or 

District Commander for a copy of 

MARSEC Directive 105–4. 

DATES: MARSEC Directive 105–4 is 

available on February 21, 2024. 

FOR FURTHER INFORMATION CONTACT: For 

information about this document call or 

email Brandon Link, Commander, U.S. 


ddrumheller on DSK120RN23PROD with NOTICES1